Lucio Cabral

Dr. Lucio Cabral


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ASAlice Simon
Alice Simon
MAMaria Inês Amaro
Maria Inês Amaro
LCLucio Cabral
Lucio Cabral
Anne Marie HealyAnne Marie Healy
Anne Marie Healy
VSValeria De Sousa
Valeria De Sousa

14 May 2011 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
DRDaniela O Ribeiro
Daniela O Ribeiro
DPDaniela C Pinto
Daniela C Pinto
LLLuis Mauricio Lima
Luis Mauricio Lima
NVNádia M Volpato
Nádia M Volpato
LCLucio Cabral
Lucio Cabral
VSValeria De Sousa
Valeria De Sousa
Background: The objective of this work was to study the vitamins B1, B2, B6 and C stability in a pediatric formulation containing high amounts of calcium in the presence of organic phosphate, amino acids, glucose, sodium chloride, magnesium sulfate, pediatric vitamins and trace elements under different conditions using developed and validated analytical methods. Methods: The study was carried out during 72 h with formulations packaged in recommended storage temperature (4°C) and 25°C, with and without photoprotection. Results: The results showed that the methodologies used for assessing the chemical stability of vitamins B1, B2, B6 and C in the formulation were selective, linear, precise and accurate. The vitamins could be considered stable in the formulation during the three days of study if stored at 4°C. When stored at 25°C vitamin C presented instability after 48 h. Conclusion: The pediatric formulation containing high amount of calcium in the presence of organic phosphate, amino acids, glucose, sodium chloride, magnesium sulphate, pediatric vitamins and trace elements packaged in bag-type trilaminate presented a shelf life of the 72 h, when maintained under refrigeration, between 2°C and 8°C. This shelf life was measured considering the vitamins studied. Further studies are needed including all the vitamins present in this formulation.

20 December 2012 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MCMaíra Assis Da Costa
Maíra Assis Da Costa
RSRafael Cardoso Seiceira
Rafael Cardoso Seiceira
CRCarlos Rodrigues
Carlos Rodrigues
CHCristiane Rodrigues Drago Hoffmeister
Cristiane Rodrigues Drago Hoffmeister
LCLucio Cabral
Lucio Cabral
HRHelvécio Vinícius Antunes Rocha
Helvécio Vinícius Antunes Rocha
AIDS constitutes one of the most serious infectious diseases, representing a major public health priority. Efavirenz (EFV), one of the most widely used drugs for this pathology, belongs to the Class II of the Biopharmaceutics Classification System for drugs with very poor water solubility. To improve EFV’s dissolution profile, changes can be made to the physical properties of the drug that do not lead to any accompanying molecular modifications. Therefore, the study objective was to develop and characterize systems with efavirenz able to improve its dissolution, which were co-processed with sodium lauryl sulfate (SLS) and polyvinylpyrrolidone (PVP). The technique used was co-micronization. Three different drug:excipient ratios were tested for each of the two carriers. The drug dispersion dissolution results showed significant improvement for all the co-processed samples in comparison to non-processed material and corresponding physical mixtures. The dissolution profiles obtained for dispersion with co-micronized SLS samples proved superior to those of co-micronized PVP, with the proportion (1:0.25) proving the optimal mixture. The improvements may be explained by the hypothesis that formation of a hydrophilic layer on the surface of the micronized drug increases the wettability of the system formed, corroborated by characterization results indicating no loss of crystallinity and an absence of interaction at the molecular level.

25 January 2016 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
LALetícia Coli Louvisse de Abreu
Letícia Coli Louvisse de Abreu
VTValerio Todaro
Valerio Todaro
PSPlinio Cunha Sathler
Plinio Cunha Sathler
LSLuiz Cláudio Rodrigues Pereira da Silva
Luiz Cláudio Rodrigues Pereira da Silva
FCFlávia Almada Do Carmo
Flávia Almada Do Carmo
LCLucio Cabral
Lucio Cabral

2 July 2018 in AAPS PharmSciTech
Verified
Journal Article
Open access
PDF file
LALilian Henriques Do Amaral
Lilian Henriques Do Amaral
FCFlavia Almada Do Carmo
Flavia Almada Do Carmo
MAMaria Inês Amaro
Maria Inês Amaro
VSValeria Pereira de Sousa
Valeria Pereira de Sousa
LSLuiz Claudio Rodrigues Pereira da Silva
Luiz Claudio Rodrigues Pereira da Silva
LCLucio Cabral
Lucio Cabral
In this study, the formation of caffeine/dapsone (CAF/DAP) cocrystals by scalable production methods, such as liquid-assisted grinding (LAG) and spray drying, was investigated in the context of the...

13 September 2020 in Critical Reviews in Toxicology
Verified
Journal Article
Closed access
JPJuliana P. Paiva
Juliana P. Paiva
RDRaiane R. Diniz
Raiane R. Diniz
ALAlvaro C. Leitão
Alvaro C. Leitão
LCLucio Cabral
Lucio Cabral
RFRodrigo Soares Fortunato
Rodrigo Soares Fortunato
MMarcelo De Padula
Marcelo De Padula
Although sunlight provides several benefits, ultraviolet (UV) radiation plays an important role in the development of various skin damages such as erythema, photoaging, and photocarcinogenesis. Despite cells having endogenous defense systems, damaged DNA may not be efficiently repaired at chronic exposure. In this sense, it is necessary to use artificial defense strategies such as sunscreen formulations. UV filters should scatter, reflect, or absorb solar UV radiation in order to prevent direct or indirect DNA lesions. However, the safety of UV filters is a matter of concern due to several controversies reported in literature, such as endocrine alterations, allergies, increased oxidative stress, phototoxic events, among others. Despite these controversies, the way in which sunscreens are tested is essential to ensure safety. Sunscreen regulation includes mandatory test for phototoxicity, but photogenotoxicity testing is not recommended as a part of the standard photosafety testing program. Although available photobiological tests are still the first approach to assess photosafety, they are limited. Some existing tests do not always provide reliable results, mainly due to limitations regarding the nature of the assessed phototoxic effect, cell UV sensitivity, and the irradiation protocols. These aspects bring queries regarding the safety of sunscreen wide use and suggest the demand for the development of robust and efficient in vitro screening tests to overcome the existing limitations. In this way, Saccharomyces cerevisiae has stood out as a promising model to fill the gaps in photobiology and to complete the mandatory tests enabling a more extensive and robust photosafety assessment.